QualityStocks would like to highlight OmniComm Systems, Inc. (OTCBB: OMCM). The company provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm Systems, Inc. has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey and the United Kingdom, as well as sales offices throughout the U.S. and Europe.
In the company’s news yesterday,
OmniComm Systems announced that Veeda Clinical Research, Inc., also known as Veeda Oncology, has joined OmniComm’s CRO Preferred Program. As part of this program, Veeda Oncology has signed an agreement to run their first study through the program, a 27-month, phase I oncology trial. This complex study will utilize OmniComm’s TrailMaster EDC suite to manage their data collection, submission, and medical coding needs.
Veeda Oncology is a specialized global oncology clinical research organization capable of handling the rigors of phase I through phase IV trials. It is dedicated to providing comprehensive clinical oncology research services internationally for the pharmaceutical and biotechnology industries. It has offices located in the United States, Europe, India, and Malaysia.
Omnicomm’s CRO Preferred Program was chosen by Veeda because of the company’s experience and expertise in conducting oncology trials. And Veeda is not the first company to do so. The addition of Veeda Oncology brings the membership total in the Program to 48 clinical research organizations. They are drawn by members exclusive benefits including sales and marketing support, training and having a having a dedicated, hosted environment all at a fixed, pay-as-you-go price.
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.